Brinda Balakrishnan's Insider Trades & SAST Disclosures

Brinda Balakrishnan's most recent trade in Aurinia Pharmaceuticals Inc was a trade of 520 Common Stock done at an average price of $5.7 . Disclosure was reported to the exchange on May 21, 2024.

Share

Note

This is a custom search result for pattern Brinda Balakrishnan.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Aurinia Pharmaceuticals Inc	Brinda Balakrishnan	Director	Sale of securities on an exchange or to another person at price $ 5.74 per share.	21 May 2024	520	17,523 (0%)	0%	5.7	2,985	Common Stock
Aurinia Pharmaceuticals Inc	Brinda Balakrishnan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 May 2023	15,234	15,234	-		-	Stock Option (right to buy)
Aurinia Pharmaceuticals Inc	Brinda Balakrishnan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 May 2023	9,310	18,043 (0%)	0%		0	Common Stock
Aurinia Pharmaceuticals Inc	Brinda Balakrishnan	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 May 2023	8,733	0	-		-	Restricted Stock Units
Aurinia Pharmaceuticals Inc	Brinda Balakrishnan	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 May 2023	8,733	8,733 (0%)	0%		-	Common Stock
Aurinia Pharmaceuticals Inc	Brinda Balakrishnan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 May 2022	14,612	14,612	-		-	Stock Option (right to buy)
Aurinia Pharmaceuticals Inc	Brinda Balakrishnan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 May 2022	8,733	8,733	-		-	Restricted Stock Unit
Aurinia Pharmaceuticals Inc	Brinda Balakrishnan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jun 2021	53,291	53,291	-		-	Stock Option (right to buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades